Generic Name
Ibandronate
FDA approval date: March 19, 2012
Classification: Bisphosphonate
Form: Injection, Tablet
What is Ibandronate?
Ibandronate sodium tablet is a bisphosphonate indicated for the treatment and prevention of postmenopausal osteoporosis.
Approved To Treat
Top Global Experts
There are no experts for this drug
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment
Related Latest Advances
There is no latest advances for this treatment